Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
FocalTherics, a global leader in robotic energy-based therapies, has initiated a proposed underwritten public offering of American Depositary Shares (ADSs) on NASDAQ. The company plans to use the net proceeds to cover operating costs, capital expenditures, and general corporate purposes. The offering is subject to market conditions and includes an …
Artisan Partners Asset Management Inc. announced that its preliminary assets under management as of July 31, 2026 totaled $183.0 billion, with $94.3 billion in Artisan Funds and Artisan Global Funds and $88.7 billion in separate accounts and other AUM. The breakdown of AUM by strategy was detailed, with various investment teams managing different a…
Fabrinet, a global provider of advanced optical packaging and precision manufacturing services, announced that its management team will present at the Rosenblatt 6th Annual Age of AI Technology Summit on August 18, 2026. The presentation will be available via live webcast and replay on the company's investor website.
Fold Holdings, Inc., the first publicly traded bitcoin financial services company, announced second quarter 2026 results reporting $6.1 million in revenue and a net loss of $9.7 million. The company eliminated $20 million of secured debt and expanded its Fold Credit Card program to over 2,000 cardholders in early access, doubling from the previous …
DoubleDown Interactive announced strong Q2 2026 financial results, with revenue rising 11.2% year-over-year to $94.3 million and earnings per fully diluted common share increasing 50.5% to $13.27. Growth was driven by the acquisition of WHOW Games GmbH and notable expansion in its Direct-to-Consumer segment, which now accounts for over 50% of total…
Arbor Realty Trust announced the closing of an $825 million commercial real estate mortgage loan securitization, issuing $730.1 million of investment grade notes and retaining $112.4 million in subordinate interests. Proceeds will be used to repay credit facility borrowings, cover transaction costs, and finance future loan originations. The securit…
Tandy Leather Factory announced its financial results for the second quarter of 2026, showing a 1.5% increase in revenue to $18.0 million and a significant rise in operating income by 722.9% year-over-year. The company improved gross margins to 64.8% and reported net income of $0.4 million compared to a net loss the previous year. Despite a reducti…
Reed's, Inc. reported its second quarter 2026 financial results with net sales decreasing to $7.5 million from $9.5 million a year ago, driven by lower volumes from national customers. However, the company demonstrated operational improvements with gross profit increasing to $1.8 million and gross margin rising to 24% from 8%. Operating expenses an…
Ferrari trades at a premium, but recent Q2 strength, a raised 2026 guide, aggressive buybacks and the most complete product lineup in decades justify owning the stock. This trade idea lays out an actionable long with entry, stop and target for a long-term holding (180 trading days), explains the fundamental drivers and balances the bull case with c…
Firefly Aerospace announced its second-quarter 2026 financial results with record revenue of $117.7 million, a 659% year-over-year increase. The company secured over six contracts in Q2, including a $144 million NASA Commercial Lunar Payload Services contract for a rapid Moon lander mission and a $75 million subcontract supporting NASA's MoonFall m…
Cardiff Oncology announced positive Phase 2 clinical trial results for onvansertib combined with FOLFIRI/bevacizumab in first-line RAS-mutated metastatic colorectal cancer at ASCO 2026. Following a successful End-of-Phase 2 meeting with the FDA, the company plans to initiate a Phase 3 registrational trial in early 2027, contingent on securing addit…
Sanara MedTech Inc. reported a 9% increase in net revenue to $28.1 million for Q2 2026 compared to Q2 2025, with strong gross margins of 93%. The company announced an expected acquisition by MiMedx, aiming to create a leading regenerative medicine company. Despite a slight net loss due to increased SG&A and interest expenses, Adjusted EBITDA improv…
Quantinuum and Oracle announced a multi-year collaboration to make Quantinuum’s Helios quantum computer available through Oracle Cloud Infrastructure’s quantum service. Financial terms and a deployment date were not disclosed. Helios will run on-site within OCI, integrate under existing governance frameworks, and be hosted in a U.S.-based Oracle AI…
SINTX Technologies provided a mid-year 2026 business update highlighting progress in commercializing its FDA-cleared SiNAPTIC Foot & Ankle Implant System, expansion of its distribution network, additional capital raises, and growth in its industrial ceramics segment. The company is moving from technology development to commercial execution, investi…
Canterbury Park Holding Corporation reported a 3.2% increase in net revenues to $16.2 million for Q2 2026 and a 29.3% increase in adjusted EBITDA to $2.6 million, reflecting growth across Casino, Pari-mutuel, and Food and Beverage operations. Despite a net loss due to an impairment charge linked to prior horserace purse overpayments, the company sh…
Black Rock Coffee Bar, Inc. announced strong second quarter 2026 results, featuring a 25.0% year-over-year increase in total revenue to $63.0 million and a 4.2% same store sales growth. The company opened 10 new stores during the quarter, expanding its footprint to 200 locations systemwide. Income from operations grew to $4.1 million, and net incom…
Inuvo, Inc. announced the retirement of its long-serving CFO Wallace Ruiz after 16 years, with Derric Ciccone appointed as President and CFO and Aleesha Parris promoted to Chief Accounting Officer. The leadership changes aim to support Inuvo's continued scaling and transformation in AI-driven advertising technology.
Snail, Inc. announced its Q2 2026 financial results showing a slight decrease in net revenues but a significant improvement in net loss. The company expanded its ARK franchise with new DLCs, saw positive early engagement with the Bellwright console launch, and showcased progress on several upcoming AAA games. Additionally, Snail introduced an AI ga…
LENZ Therapeutics reported $5.5 million revenue in Q2 2026 driven by VIZZ (aceclidine ophthalmic solution) sales and global licensing agreements. Strong patient refill rates and the launch of a telehealth prescribing channel in July 2026 are early indicators of sustained growth. The company expanded international partnerships and regulatory submiss…
Bolt Biotherapeutics announced its second quarter 2026 financial results and provided an update on its lead candidate BDC-4182, a Boltbody ISAC targeting claudin 18.2 for gastric and gastroesophageal cancers. The Phase 1/2 clinical trial is ongoing with patients in Cohort 4 and initial clinical data are expected in Q3 2026. The company had $18.1 mi…
Codexis, Inc. reported Q2 2026 revenue of $14.9 million and reiterated full-year guidance. The company highlighted advances in its ECO Synthesis® Manufacturing Platform enabling enzyme-driven stereoisomer control of siRNA, strengthening its position in RNA therapeutics manufacturing. A successful $25 million equity raise enhanced its cash position …
Spectral AI announced its Q2 2026 financial results, highlighting FDA clearance for its DeepView® System for burn indication and a strong cash position of $14 million. The company received $31.7 million in BARDA funding and is positioned to commence first commercial sales by the end of 2026. Despite a net loss of $4.2 million for the quarter, the c…
Pliant Therapeutics, a clinical-stage biotech focused on integrin therapeutics, provided a corporate update highlighting strong enrollment in its Phase 1b FORTIFY trial for PLN-101095 in ICI-refractory solid tumors. The company appointed experienced oncology drug development leaders to its board, showcased promising biomarker data indicating tumor …
GrowGeneration Corp., a leading supplier in controlled environment agriculture and commercial cultivation, reported a 5.5% year-over-year sales increase to $43.2 million in Q2 2026 alongside an improved net loss and positive Adjusted EBITDA. The company enhanced its proprietary brand penetration to nearly 40% of cultivation sales and strengthened i…
MacroGenics announced that Gilead Sciences has exercised its option under their 2022 collaboration agreement to exclusively license a preclinical bispecific program targeting solid tumors. This action triggers a $10 million milestone payment to MacroGenics. The collaboration includes one clinical-stage and two preclinical bispecific programs, with …
